rs200403177
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_006231.4(POLE):c.1336C>T(p.Arg446Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000174 in 1,613,218 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R446Q) has been classified as Likely benign.
Frequency
Consequence
NM_006231.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250528Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135562
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1460916Hom.: 0 Cov.: 34 AF XY: 0.0000248 AC XY: 18AN XY: 726836
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74460
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 446 of the POLE protein (p.Arg446Trp). This variant is present in population databases (rs200403177, gnomAD 0.01%). This missense change has been observed in individual(s) with colorectal cancer (PMID: 29120461). ClinVar contains an entry for this variant (Variation ID: 421572). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on POLE protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This variant is denoted POLE c.1336C>T at the cDNA level, p.Arg446Trp (R446W) at the protein level, and results in the change of an Arginine to a Tryptophan (CGG>TGG). This variant has not, to our knowledge, been published in the literature as either a pathogenic germline variant or a benign polymorphism. However, it has been reported as a somatic variant in at least one endometrial tumor (Billingsley 2015). POLE Arg446Trp was not observed at significant allele frequency in the NHLBI Exome Sequencing Project. Since Arginine and Tryptophan differ in polarity, charge, size or other properties, this is considered a non-conservative amino acid substitution. POLE Arg446Trp occurs at a position that is conserved in mammals and is located within the exonuclease domain (Preston 2010). In silico analyses predict that this variant is probably damaging to protein structure and function. Based on currently available evidence, it is unclear whether POLE Arg446Trp is a pathogenic or benign variant. We consider it to be a variant of uncertain significance. -
Hereditary cancer-predisposing syndrome Uncertain:2
The p.R446W variant (also known as c.1336C>T), located in coding exon 13 of the POLE gene, results from a C to T substitution at nucleotide position 1336. The arginine at codon 446 is replaced by tryptophan, an amino acid with dissimilar properties. In one family, this alteration was detected in an individual with colorectal cancer diagnosed at age 45, two of this individual's siblings with lower limb cancers, and another sibling with breast cancer. Two additional unaffected siblings and an unaffected paternal aunt from this family tested negative for this alteration (Buchanan DD et al. Genet Med, 2018 08;20:890-895). In another study, this variant was not detected in 165 colorectal cancer and/or polyposis patients and was identified in 1/2512 control individuals from a healthy population database (Rosenthal EA et al. Hum Genet, 2018 Oct;137:795-806). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
- -
Colorectal cancer, susceptibility to, 12 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at